메뉴 건너뛰기




Volumn 157, Issue 3, 2012, Pages 397-400

Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients

Author keywords

Bleeding disorders; Cardiology; Coagulation; Factor VII; Transfusion medicine

Indexed keywords

FIBRINOGEN; PROTHROMBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

EID: 84859512152     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08992.x     Document Type: Letter
Times cited : (4)

References (10)
  • 1
    • 27744513120 scopus 로고    scopus 로고
    • Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study
    • Diprose, P., Herbertson, M.J., O'Shaughnessy, D. & Gill, R.S. (2005) Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. British Journal of Anaesthesia, 95, 596-602.
    • (2005) British Journal of Anaesthesia , vol.95 , pp. 596-602
    • Diprose, P.1    Herbertson, M.J.2    O'Shaughnessy, D.3    Gill, R.S.4
  • 2
    • 39149143018 scopus 로고    scopus 로고
    • Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry
    • Dunkley, S., Phillips, L., McCall, P., Brereton, J., Lindeman, R., Jankelowitz, G. & Cameron, P. (2008) Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Annals of Thoracic Surgery, 85, 836-844.
    • (2008) Annals of Thoracic Surgery , vol.85 , pp. 836-844
    • Dunkley, S.1    Phillips, L.2    McCall, P.3    Brereton, J.4    Lindeman, R.5    Jankelowitz, G.6    Cameron, P.7
  • 3
    • 33745431704 scopus 로고    scopus 로고
    • Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy
    • Ekert, H., Brizard, C., Eyers, R., Cochrane, A. & Henning, R. (2006) Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagulation and Fibrinolysis, 17, 389-395.
    • (2006) Blood Coagulation and Fibrinolysis , vol.17 , pp. 389-395
    • Ekert, H.1    Brizard, C.2    Eyers, R.3    Cochrane, A.4    Henning, R.5
  • 4
    • 0033060331 scopus 로고    scopus 로고
    • Recombinant Factor VIIa does not induce hypercoagulability in vitro
    • Gallistl, S., Cvirn, G. & Muntean, W. (1999) Recombinant Factor VIIa does not induce hypercoagulability in vitro. Thrombosis and Haemostasis, 81, 245-249.
    • (1999) Thrombosis and Haemostasis , vol.81 , pp. 245-249
    • Gallistl, S.1    Cvirn, G.2    Muntean, W.3
  • 5
    • 67651089555 scopus 로고    scopus 로고
    • Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery
    • Gill, R., Herbertson, M., Vuylsteke, A., Olsen, P.S., von Heymann, C., Mythen, M., Sellke, F., Booth, F. & Schmidt, T.A. (2009) Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation, 120, 21-27.
    • (2009) Circulation , vol.120 , pp. 21-27
    • Gill, R.1    Herbertson, M.2    Vuylsteke, A.3    Olsen, P.S.4    von Heymann, C.5    Mythen, M.6    Sellke, F.7    Booth, F.8    Schmidt, T.A.9
  • 6
    • 62349083053 scopus 로고    scopus 로고
    • Efficacy and safety of activated recombinant factor VII in cardiac surgical patients
    • Hardy, J.F., Belisle, S. & Van der Linden, P. (2009) Efficacy and safety of activated recombinant factor VII in cardiac surgical patients. Current opinion in anaesthesiology, 22, 95-99.
    • (2009) Current opinion in anaesthesiology , vol.22 , pp. 95-99
    • Hardy, J.F.1    Belisle, S.2    Van der Linden, P.3
  • 8
    • 62949109594 scopus 로고    scopus 로고
    • Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage
    • Lewis, N.R., Brunker, P., Lemire, S.J. & Kaufman, R.M. (2009) Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage. Transfusion, 49, 689-695.
    • (2009) Transfusion , vol.49 , pp. 689-695
    • Lewis, N.R.1    Brunker, P.2    Lemire, S.J.3    Kaufman, R.M.4
  • 9
    • 34249821653 scopus 로고    scopus 로고
    • Prevention and treatment of major blood loss
    • Mannucci, P.M. & Levi, M. (2007) Prevention and treatment of major blood loss. New England Journal of Medicine, 356, 2301-2311.
    • (2007) New England Journal of Medicine , vol.356 , pp. 2301-2311
    • Mannucci, P.M.1    Levi, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.